Earnings Call · Q3 FY2021·2021-11-03

Q3 21EPS +11.11%·Rev n/aQ2 21EPS +35.00%·Rev n/aQ1 21EPS +28.57%·Rev n/aQ4 20EPS +85.71%·Rev n/a⚠ consensus missing

LEXICON PHARMACEUTICALS, INC. LXRX

Chas Schultz — Unknown

Lonnel Coats — Chief Executive Officer

Craig Granowitz — Senior Medical Officer

Jeff Wade — President and Chief Financial Officer

−13.9%1d on move date−14.3% vs SPY3d−12.5%5d−15.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LXRX calls or request research access.

More LXRX calls Browse calls Request research access